CMG
67
3
TROW
51
3
PRU
62
5
FDX
40
4
ITW
62
4
ZTS
49
2
GT
56
2
NWL
50
6
PCAR
56
3
GIS
28
2
INTU
54
3
ISRG
76
2
ADSK
68
2
AON
52
2
IVZ
48
2
AMP
73
4
AA
60
9
HD
55
8
V
66
6
GLW
46
4
CMG
67
3
TROW
51
3
PRU
62
5
FDX
40
4
ITW
62
4
ZTS
49
2
GT
56
2
NWL
50
6
PCAR
56
3
GIS
28
2
INTU
54
3
ISRG
76
2
ADSK
68
2
AON
52
2
IVZ
48
2
AMP
73
4
AA
60
9
HD
55
8
V
66
6
GLW
46
4
Financhill
Back

Equillium Vs. Matinas BioPharma Holdings Industry Stock Comparison

Sell
34

EQ
Equillium

Last Price:
0.73
Seasonality Move:
46.01%
Sell
38

MTNB
Matinas BioPharma Holdings

Last Price:
0.63
Seasonality Move:
5.28%
Sell
34
Equillium (EQ) is a Sell

Is Equillium a Buy, Sell or Hold?

  • The current Equillium [EQ] share price is $0.72. The Score for EQ is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • EQ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Matinas BioPharma Holdings (MTNB) is a Sell

Is Matinas BioPharma Holdings a Buy, Sell or Hold?

  • The current Matinas BioPharma Holdings [MTNB] share price is $0.58. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • MTNB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EQ Stock Price Chart

What is Equillium's stock price today?

  • The Equillium share price today is $0.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EQ is experiencing buying pressure, which is a positive indicator for future bullish movement.

MTNB Stock Price Chart

What is Matinas BioPharma Holdings's stock price today?

  • The Matinas BioPharma Holdings share price today is $0.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing buying pressure, which is a positive indicator for future bullish movement.

EQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 40.62 Sell
Chaikin Money Flow: 74091 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.69 - 1.15) Sell
Bollinger Bands (100): (0.72 - 1.02) Sell

MTNB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.57 Sell
Relative Strength Index (14 RSI): 23.95 Sell
Chaikin Money Flow: 119933 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.26 - 2.88) Sell
Bollinger Bands (100): (0 - 3.16) Sell

EQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.73 Sell
20-day SMA: 0.87 Sell
50-day SMA: 0.9 Sell
200-day SMA: 1.31 Sell
8-day EMA: 0.73 Sell
20-day EMA: 0.81 Sell
50-day EMA: 0.88 Sell
200-day EMA: 1.04 Sell

MTNB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.63 Sell
20-day SMA: 1.06 Sell
50-day SMA: 2.51 Sell
200-day SMA: 0.89 Sell
8-day EMA: 0.65 Sell
20-day EMA: 1.14 Sell
50-day EMA: 1.73 Sell
200-day EMA: 1.19 Sell

Equillium Earnings Growth & EQ Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and a decrease next year of $0.91 per share.

Matinas BioPharma Holdings Earnings Growth & MTNB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $1.06 per share.

Equillium Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Matinas BioPharma Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):